China Universal Asset Management »

Alpine Immune Sciences shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $501k 13k 39.67
2023-12-31 $128k 6.7k 19.04
2023-09-30 $15k 1.3k 11.82
2023-06-30 $6.0k 629 9.54
2023-03-31 $5.0k 623 8.03
2022-12-31 $3.0k 467 6.42
2022-09-30 $2.0k 285 7.02

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Cormorant Asset Management
OrbiMed Advisors
Vanguard Group
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors
Henderson Group

View all funds holding Alpine Immune Sciences